AARON ROYSTON

Profile

First Name

: AARON

Middle Name

:

Last Name

: ROYSTON

Related Companies
Titles
Company Name
Related People
DIRECTOR
IMPEL NEUROPHARMA INC
ADRIAN ADAMS, DAVID ALLISON, JON CONGLETON, MICHAEL HITE, MICHAEL P. HITE, RODNEY HO, JOHN D. HOEKMAN, JOHN LEAMAN, ROBERT MITTENDORFF, TIM NELSON, STEWART PARKER, ALI SATVAT, MAHENDRA SHAH, DIANE WILFONG, JIM YOUNG
DIRECTOR
MENLO THERAPEUTICS, INC.
SHARON BARBARI, STEVEN BASTA, STEVEN L. BASTA, ANTHONY BRUNO, ALBERT CHA, DAVID COLLIER, JOHN CREECY, DAVID DOMZALSKI, TED EBEL, MUTYA HARSCH, JAMES LARRICK, PATRICK LEPORE, KETAN PATEL, ANDREW PERLMAN, ELISABETH SANDOVAL, EDWARD SCHNIPPER, IAIN STUART, SCOTT WHITCUP, TYLER ZERONDA
DIRECTOR
HARMONY BIOSCIENCES II, INC.
JEFFREY ARONIN, OCTAGON CAPITAL GROUP, LLC, MARTIN EDWARDS, WILBUR GANTZ III, WILBUR GANTZ, III, ANTONIO GRACIAS, JOHN JACOBS, PATRICK MORRIS, JACK NIELSEN, JACK BECH NIELSEN, DARIEN PARHAD, ROBERT REPELLA, JUAN SABATER, ANDREW SERAFIN, JOHN VITTORIA, DR. ANDREAS WICKI
DIRECTOR
AKERO THERAPEUTICS, INC.
KEVIN BITTERMAN, ANDREW CHENG, MARK IWICKI, AARON KANTOFF, GRAHAM WALMSLEY, JONATHAN YOUNG
EXECUTIVE OFFICER
VENBIO GLOBAL STRATEGIC FUND III, L.P.
ROBERT ADELMAN, COREY GOODMAN, DAVID PEZESHKI, N/A VENBIO GLOBAL STRATEGIC GP III, L.P., N/A VENBIO GLOBAL STRATEGIC GP III, LTD.
DIRECTOR
SWIFT HEALTH SYSTEMS INC.
GLEN R. ANDERSON, ROBERT BARMANN, CLINT CARNELL, KENNY CHANG, KEVIN J COUSINS, VIJAY DHAKA, ANDREW GOLDBERG, RICHARD IVERSON, PETER MOLDT, PHILONG PHAM, W. RONALD REDMOND, WILLIAM RONALD REDMOND, JOSEPH SILETTO, HONGSHENG TONG
DIRECTOR
RAYZEBIO, INC.
DEBORAH CHARYCH, JEREL DAVIS, AUBREY HADDACH, AARON KANTOFF, MAHA KATABI, BONG KOH, ARVIND KUSH, YI LARSON, ALEX ROSEN, KEN SONG, MARY TAGLIAFERRI, ANGIE YOU
EXECUTIVE OFFICER
VENBIO GLOBAL STRATEGIC FUND IV, L.P.
ROBERT ADELMAN, RICHARD GASTER, COREY GOODMAN, DAVID PEZESHKI, N/A VENBIO GLOBAL STRATEGIC GP IV, LLC, N/A VENBIO MANAGEMENT COMPANY LLC
DIRECTOR
VENTYX BIOSCIENCES, INC.
MARTIN AUSTER, ONAIZA CADORET-MANIER, JIGAR CHOKSEY, MARK S. FORMAN, RICHARD GASTER, SHEILA GUJRATHI, ALLISON HULME, CHRISTOPHER W. KRUEGER, RAJU MOHAN, MATTHEW MOORE, JOHN NUSS, SOMASUNDARAM SUBRAMANIAM, WILLIAM WHITE
DIRECTOR
NEUROGASTRX, INC.
DAVID ALLISON, CYRIL DE COLLE, JAMES DETORE, KEVIN KOCH, JAMES O-MARA, PAUL ROGERS, KLAUS VEITINGER, KLAUS VETTINGER
DIRECTOR
MAREA THERAPEUTICS, INC.
ANTOINE BOULANGER, JUNG CHOI, CHRIS GARABEDIAN, CHRISTINE GARRETT, MARK JOING, MAHA KATABI, JOSH LEHRER, TED LOVE, CAITLIN MURRAY, JEFF TONG, ETHAN WEISS
EXECUTIVE OFFICER
VENBIO GLOBAL STRATEGIC FUND V, L.P.
ANTOINETTE DELHONTE, RICHARD GASTER, COREY GOODMAN, DAVID PEZESHKI, N/A VENBIO GLOBAL STRATEGIC GP V, LLC, N/A VENBIO PARTNERS LLC, YVONNE YAMANAKA
DIRECTOR
ARPEGGIO BIOSCIENCES, INC.
DAVID ALLISON, JOSEPH G. AZOFEIFA, MIRA CHAURUSHIYA, ROBIN D. DOWELL-DEEN, SAMUEL KINTZ, ERIC MARTIN, JOE MCMAHON, AMIT MEHTA, LAURA NORRIS, TIMOTHY READ, DANIEL WEAVER
DIRECTOR
CALDERA THERAPEUTICS, INC.
MICHELLE DOIG, MICHAEL GLADSTONE, XIAODI SU, PRAVEEN TIPIRNENI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-01-08 
2025-11-24
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-12 
2024-07-12
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2024-06-28 
2024-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-11 
2022-09-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-08-25 
2021-09-20
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-09 
2021-09-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
2021-07-16
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2021-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-25 
2021-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-18 
2021-06-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-08 
2021-05-14
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-04-30 
2021-04-01
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-03-18 
2021-03-12
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-03-05 
2021-02-17
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-02-09 
2020-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-23 
2020-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-05 
2020-05-06
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-05-04 
2020-03-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-06-14 
2020-01-30
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-01-23 
2019-08-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-07-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
2019-07-03
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-06-24 
2019-03-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-06-14 
2019-02-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2019-02-08 
2018-12-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
2018-01-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-08 
2017-10-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-22 
2017-07-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2016-12-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-16